E500 Screenless Medical ECG Wearable Sensor
- Continuous ECG & Multi-Wave PPG
- Febrile Neutropenia Temp Tracking
- IP68 Submersible Waterproofing
- Screenless Design for Adherence
CE-MDR (EU 2017/745) Certified
FDA 510(k) Cleared
ISO 13485 Manufacturing Quality
German DSGVO & GDPR Compliant
Up to 128 Hz Raw Signal Export
Recommended Medical Wearable Sensors for Oncology Trials in Germany
Specially engineered for continuous patient monitoring during immunotherapeutic, chemotherapeutic, and targeted oncology trials. Certified for clinical research across German University Hospitals and global CRO networks.
VALDUS VITRO Clinical Research ECG Bracelet
- Single-Lead Clinical ECG Rhythm Strip
- Continuous Blood Oxygen (SpO2)
- OEM/ODM Custom Protocol Firmware
- Ultra-Lightweight Ergonomic Band
V6G 4G Cellular Telemetry Clinical Wearable
- Direct 4G Cellular Gateway Connection
- GPS & Emergency Fall Detection
- Real-Time SpO2 & Cardiac Rhythm
- Ideal for Decentralized Trials (DCT)
Precision Steel ECG Biomarker Trial Bracelet
- Biocompatible Medical-Grade Steel
- High-Resolution ECG Waveform Capture
- Magnetic Quick-Charge System
- Discreet Profile for Senior Cohorts
G70 Screenless Multi-Sensor Oncology Band
- Continuous Skin & Core Temp Derivation
- Raw PPG Signal Access (Up to 128Hz)
- Sleep Staging & HRV Autonomic Status
- 14-Day Extended Battery Life
VITRO 1ATM Waterproof ECG Research Band
- 1ATM Continuous Water Resistance
- Integrated Bluetooth 5.2 Low Energy
- iOS & Android Research SDK Support
- Remote Parameter Alarm Thresholds
Long-Battery Screenless Clinical Biosensor
- 180mAh Cell (15-Day Continuous Wear)
- 3ATM Medical Grade Water Proofing
- Optical SpO2 & Rhythm Strip Log
- Zero Data Loss Internal Flash Memory
2026 E500 Clinical Trial NFC Biosensor
- Encrypted NFC Patient Check-In Link
- Continuous Blood Pressure Derivation
- Precision Micro-Calorimetric Temp Sensor
- Full API/SDK Data Pipeline Integration
Proven Clinical Track Record in European & German Healthcare
400B+
Physiological Data Points
High-fidelity continuous vital parameters captured across active oncology, cardiology, and surgical protocols.
200+
Clinical Trials Supported
Deployments across global Contract Research Organizations (CROs) and university clinical trial sites.
35+
Hospital Networks
Active general ward monitoring, oncology day-clinics, and post-discharge continuous patient surveillance.
Transforming German Oncology Research with Continuous Wearable Sensing
Information Gain Insight: Traditional oncology clinical trials rely on episodic clinical site visits every 2 to 4 weeks. This introduces severe monitoring blind spots between cycles of chemotherapy or immunotherapy. Continuous wearable multi-sensor telemetry captures dynamic physiological micro-changes—enabling early intervention for drug-induced cardiotoxicity and febrile neutropenia prior to severe adverse event escalation.
As oncology research transitions rapidly toward Decentralized Clinical Trials (DCTs) and hybrid monitoring protocols across Germany and the European Union, contract research organizations (CROs), sponsor pharmaceutical companies, and university medical centers require validated, high-fidelity physiological monitoring tools. Evaluating novel oncology therapeutics—such as Immune Checkpoint Inhibitors (ICIs), Chimeric Antigen Receptor (CAR)-T cell therapies, and antibody-drug conjugates (ADCs)—demands continuous surveillance of patient physiological parameters.
Key Localized Application Scenarios in German Clinical Oncology
Continuous Febrile Neutropenia Early Detection
Chemotherapy-induced neutropenia exposes oncology patients to severe, life-threatening infections. Continuous skin and core-derived temperature monitoring, coupled with Autonomic Nervous System (ANS) tone derived from Heart Rate Variability (HRV), allows research teams at German comprehensive cancer centers to spot pyrexic onset hours before traditional manual thermometry.
Chemotherapy-Induced Cardiotoxicity Surveillance
Cardiotoxicity remains a primary dose-limiting factor for anthracyclines, HER2 inhibitors (e.g., Trastuzumab), and kinase inhibitors. Utilizing medical-grade, single-lead continuous ECG sensors enables automated detection of QT/QTc interval prolongation, ST-segment elevation, and emerging arrhythmias in out-of-hospital trial participants across Germany.
Digitalized ECOG / Karnofsky Performance Status
Replacing subjective, physician-assessed physical performance scales with objective 3-axis accelerometer data. Continuous actigraphy tracks patient fatigue dynamics, circadian sleep disruption, and post-infusion recovery velocity directly within the patient’s home setting.
Regulatory Landscape & Supply Trends for Clinical Trials in Germany
Operating clinical research within Germany demands strict adherence to both national standards and broader European Union frameworks. As a dedicated exporter and supplier to German pharmaceutical research consortia, our medical-grade wearable sensors are engineered to satisfy the rigorous criteria established by German ethics committees and federal regulators:
1. EU Clinical Trials Regulation (CTR) No 536/2014 & BfArM Guidelines
The implementation of EU CTR No 536/2014 has streamlined clinical trial applications via the Clinical Trials Information System (CTIS), but has elevated the necessity for validated digital endpoints. The Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) mandates that wearable medical sensors deployed for primary, secondary, or exploratory trial endpoints possess verifiable clinical accuracy and ISO 13485 manufacturing lineage.
2. German Data Protection Act (DSGVO / GDPR) & Data Sovereignty
German clinical trial sites (including lead sites such as Charité - Universitätsmedizin Berlin, NCT Heidelberg, and LMU Klinikum München) maintain stringent interpretation of data privacy laws. Our monitoring infrastructure enforces strict separation of Patient Identifiable Information (PII) from continuous physiological signals. Raw data streams can be routed directly to local EU-hosted cloud infrastructure or on-premise clinical data servers, guaranteeing zero unauthorized data transfers outside the European Economic Area.
3. Compliance with EU-MDR (EU 2017/745) Class IIa Medical Device Certification
Unlike consumer fitness bands that rely on proprietary, unvalidated estimations, our recommended oncology wearables are regulated medical devices certified under CE-MDR by audited Notified Bodies (such as Kiwa). This certification ensures that cardiac rhythm, respiratory rate, and blood oxygenation data collected during clinical protocols are audit-ready for regulatory approval dossiers submitted to the EMA or FDA.
Equip Your Oncology Clinical Protocol with Certified Sensors
Need custom firmware, raw signal APIs, or localized trial logistics for your German clinical sites? Contact our clinical research support engineers today.
Contact UsCollaborating with Global Healthcare Leaders & German Institutions
Our biosensors and continuous monitoring platform are integrated into research initiatives and distribution channels alongside premier pharmaceutical firms, MedTech pioneers, and renowned academic medical centers across Europe.
Why German CROs & Oncology Sponsors Partner With Us
Unrestricted Raw Signal Access (128 Hz)
We eliminate vendor algorithm lock-in. Access raw multi-wavelength Photoplethysmography (PPG: Green, Red, Infrared), single-lead ECG rhythm strips, 3-axis Accelerometry, Skin Temperature, and Galvanic Skin Response (GSR) at up to 128 Hz for custom AI digital biomarker discovery.
High Trial Adherence & Screenless Design
Oncology clinical trial participants often experience severe fatigue. Our screenless, lightweight form factors prevent patient anxiety caused by real-time vital sign fluctuations while ensuring maximum battery longevity and zero accidental operational errors.
Full EMR & EDC Platform Integration
Streamline trial data collection directly into electronic data capture (EDC) systems like Medidata Rave, Veeva, or REDCap. Documented RESTful APIs and native mobile SDKs (iOS/Android) allow continuous telemetry integration into existing trial gateways.
Frequently Asked Questions: Wearable Sensors in German Oncology Trials
Q: Are these wearable sensors compliant with German DSGVO (GDPR) standards?
Yes. All data pipelines, cloud gateway applications, and SDK modules strictly adhere to German DSGVO requirements. Patient identifiers are fully pseudonymized at the gateway level before transmission. Data hosting can be directed exclusively to EU-located data centers (e.g., Frankfurt AWS/Azure region) or self-hosted on institutional servers at German university hospitals.
Q: Can our research biostatisticians access unprocessed raw PPG and ECG data?
Absolute raw signal access is a cornerstone of our research technology. We provide IP-free, unencrypted export of raw accelerometer, multi-wavelength PPG, single-lead ECG waveforms, and skin temperature data sampled at up to 128 Hz via API endpoints or bulk CSV/JSON export modules.
Q: What is the regulatory clearance status of your clinical wearables under EU-MDR?
Our lead research wearables (including CardioWatch 287 platform technology) hold CE-MDR Class IIa certification audited under EU 2017/745 regulation by Kiwa Notified Body (CE 1984), alongside FDA 510(k) clearance. This guarantees that parameters measured meet rigorous clinical validation criteria for exploratory, secondary, and primary research endpoints.
Q: How do you support logistics and customs clearance for clinical trial sites in Germany?
We provide comprehensive end-to-end export services, including direct-to-site shipping across all German federal states (Baden-Württemberg, Bavaria, Berlin, North Rhine-Westphalia, etc.). Products are shipped fully customs-cleared under DDP (Delivered Duty Paid) terms with complete EU MDR Declaration of Conformity documentation and CE marking.
Q: How do screenless sensors improve trial compliance in oncology patient cohorts?
In oncology studies, interactive screens often trigger patient distress due to continuous vital sign viewing and increase accidental button presses. Screenless sensors function as passive, continuous telemetry devices with multi-week battery endurance—significantly reducing patient burden and preventing protocol dropouts.
Q: Can we customize sensor firmware or mobile applications for trial-specific protocols?
Yes. We offer comprehensive OEM/ODM engineering services for clinical research sponsors. This includes custom PPG/ECG sampling frequencies, specialized event-triggering algorithms (such as acute hyperthermia alerts for febrile neutropenia), white-labeled mobile gateway apps, and bespoke packaging.
Initiate Your Oncology Wearable Telemetry Deployment
Contact our clinical trial deployment specialists to review technical datasheets, order evaluation units, or request API integration documentation for your upcoming trial in Germany or across Europe.
Contact Us